Twenty-three sufferers had therapy refractory HLH (13 principal, 4 EVB-HLH, 6 HLH without known trigger)
Twenty-three sufferers had therapy refractory HLH (13 principal, 4 EVB-HLH, 6 HLH without known trigger). sufferers who received the supplement blocker eculizumab as well as… Read More »Twenty-three sufferers had therapy refractory HLH (13 principal, 4 EVB-HLH, 6 HLH without known trigger)